当前位置:首页 - 行情中心 - 颖泰生物(920819) - 财务分析 - 现金流量表

颖泰生物

(920819)

  

流通市值:36.71亿  总市值:37.14亿
流通股本:12.12亿   总股本:12.26亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,902,753,940.321,077,683,127.314,079,930,922.792,995,892,498.93
  收到的税费返还131,895,254.8359,718,961.7258,554,565.75208,138,076.85
  收到其他与经营活动有关的现金61,933,869.1258,907,459.59102,359,785.7657,009,660.75
  经营活动现金流入小计2,096,583,064.271,196,309,548.64,440,845,274.33,261,040,236.53
  购买商品、接受劳务支付的现金1,410,934,705.28798,256,916.372,770,561,616.042,272,915,209.44
  支付给职工以及为职工支付的现金342,450,935.94196,543,959.38657,950,188.96503,742,692.79
  支付的各项税费82,532,932.0144,124,419.01141,705,637.09110,447,062.31
  支付其他与经营活动有关的现金89,498,652.7754,369,575.23271,639,383.01180,288,315.05
  经营活动现金流出小计1,925,417,2261,093,294,869.993,841,856,825.13,067,393,279.59
  经营活动产生的现金流量净额171,165,838.27103,014,678.61598,988,449.2193,646,956.94
二、投资活动产生的现金流量:
  收回投资收到的现金107,328,00064,832,000115,580,00070,000,000
  取得投资收益收到的现金17,115,680.665,508,144.1835,541,595.3621,137,967.2
  处置固定资产、无形资产和其他长期资产收回的现金净额551,605.22111,078.2225,025,006.8423,332,803.84
  投资活动现金流入小计124,995,285.8870,451,222.4176,146,602.2114,470,771.04
  购建固定资产、无形资产和其他长期资产支付的现金76,482,699.454,503,775.93163,529,075.74141,659,531.96
  投资支付的现金--99,000,000-
  支付其他与投资活动有关的现金--282,450242,000
  投资活动现金流出小计76,482,699.454,503,775.93262,811,525.74141,901,531.96
  投资活动产生的现金流量净额48,512,586.4815,947,446.47-86,664,923.54-27,430,760.92
三、筹资活动产生的现金流量:
  取得借款收到的现金1,508,304,375.41718,042,578.884,660,729,985.443,880,081,175.01
  收到其他与筹资活动有关的现金9,063,200.910,287,208.9418,595,234.6370,185,620.89
  筹资活动现金流入小计1,517,367,576.31728,329,787.824,679,325,220.073,950,266,795.9
  偿还债务支付的现金1,665,166,004.17798,071,571.234,823,832,428.373,836,691,523.82
  分配股利、利润或偿付利息支付的现金77,516,182.2236,842,438.78175,736,115.5127,014,207.61
  其中:子公司支付给少数股东的股利、利润7,200,000-3,780,0003,780,000
  支付其他与筹资活动有关的现金22,934,856.085,879,492.04105,661,543.87198,623,385.19
  筹资活动现金流出小计1,765,617,042.47840,793,502.055,105,230,087.744,162,329,116.62
  筹资活动产生的现金流量净额-248,249,466.16-112,463,714.23-425,904,867.67-212,062,320.72
四、汇率变动对现金及现金等价物的影响-11,018,685.01-5,104,944.286,196,484.868,140,819.21
五、现金及现金等价物净增加额-39,589,726.421,393,466.5792,615,142.85-37,705,305.49
  加:期初现金及现金等价物余额621,472,058.86621,472,058.86528,856,916.01528,856,916.01
  期末现金及现金等价物余额581,882,332.44622,865,525.43621,472,058.86491,151,610.52
补充资料:
  净利润3,899,489.49--260,398,538.1-
  资产减值准备--95,483,872.25-
  固定资产和投资性房地产折旧209,656,404.83-436,870,869.58-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧209,656,404.83-436,870,869.58-
  无形资产摊销--40,731,784.01-
  长期待摊费用摊销3,400,419.19-5,840,120.71-
  处置固定资产、无形资产和其他长期资产的损失-3,608.51--13,433,851.23-
  固定资产报废损失1,011,497.95-2,823,314-
  公允价值变动损失7,940,809.61-1,370.4-
  财务费用84,653,023.67-149,960,419.26-
  投资损失-30,500,342.49-61,730,501.82-
  递延所得税-9,218,335.72--52,606,012.36-
  其中:递延所得税资产减少-8,879,495.97--50,558,128.34-
    递延所得税负债增加-338,839.75--2,047,884.02-
  存货的减少-48,414,097.08-175,919,720.41-
  经营性应收项目的减少-1,525,805.28--85,358,560.11-
  经营性应付项目的增加-87,340,683.6--3,471,739.46-
  其他--174,981.28-
  现金的期末余额581,882,332.44-621,472,058.86-
  减:现金的期初余额621,472,058.86-528,856,916.01-
  现金及现金等价物的净增加额-39,589,726.42-92,615,142.85-
公告日期2026-08-142026-04-242026-04-162025-10-24
审计意见(境内)标准无保留意见
TOP↑